Health organizations across the Toronto Academic Health Science Network are taking action to improve sustainability in health care — and better prepare for the health impacts of climate change.

University of Toronto researchers have discovered nine new genes used by bacteria to protect themselves against phages – viruses that infect them. The findings could have profound implications for the development of strategies to treat bacterial infections, particularly those that are drug resistant.

University of Toronto researchers have co-founded Northern Vascular Systems (NVS), a medical technology company improving neurovascular disorder treatment. The startup is based on technology developed at Sunnybrook Research Institute by Yuta Dobashi, a PhD candidate at U of T’s Institute of Medical Science.

Last week, the University of Toronto hosted its ninth annual Entrepreneurship Week to showcase and celebrate innovation and startup activity. Whether as founders, panelists or attendees, I was delighted to see so many members of the Temerty Medicine community take part in the events.We have a proud history of enabling discoveries that have laid the groundwork for new therapies, devices, tools and policies that improved the lives of people around the world. Scientific inquiry will always remain a core part of our mission as a world-class hub for biomedical research, education and clinical care, but increasingly, we recognize the importance of taking our work one step further — to market.